RSF1 and cancer: Chen et al. silenced Rsf-1 in NSCLC by CRISPR/Cas9, which inhibited cancer cell inhibition and migration and promoted cancer cell apoptosis, demonstrating that Rsf-1 regulates NF-κ B pathways to influence NSCLC sensitivity to paclitaxel (Chen et al., 2017).